After deciding this week that its CEO needs to be based in Eagan, Minn., and with chief executive Chris von Jako unwilling to relocate his family, Dynatronics (NSDQ:DYNT) promoted COO Brian Baker to the corner office, effective August 28. “After thoughtful consideration, the board of directors determined that the company’s CEO needs to be based in […]
Texas doc nearly clear of over-stenting charges | Legal News
Dr. Samuel DeMaio
A Texas doctor accused of unnecessary stenting has slipped three of four trials against him with his license to practice in the Lone Star State intact.
Dr. Samuel DeMaio, accused last year of standard-of-care violations related to nine patients who allegedly received un-needed stents, angiograms and ICD implants, had pushed for a trial after mediation efforts with the Texas Medical Board collapsed.
Abiomed, Thoratec and Heartware listed as potential buyout candidates by UBS
Abiomed Inc.’s (NSDQ:ABMD recent good fortune may make it a prime acquisition target, according to Wall Street analysts.
BSX outlook gets mixed reviews from Wall Street
Boston Scientific Corp. (NYSE:BSX) garnered two upgrades and one downgrade from analysts this week, creating a roller-coaster effect in stock prices for the medical device giant.
The company’s stock has been closing at higher and higher values all week, but slid nearly 4 percent in midday trading Friday after an analyst at wealth management service UBS downgraded the stock from buy to neutral.
Wall Street analyst Rajeev Jashnani said the stock isn’t likely to trade higher until BSX can report sustained revenue.
MassDevice Network
@MassDevice
LinkedIn
YouTube